BIOMATCAN expands market reach with ACOA support

Fredericton-based BIOMATCAN is a Canadian biotechnology and medical-device company that develops and manufactures advanced materials for human and veterinary use. By combining scientific research, regulatory expertise and advanced manufacturing, the company brings innovative healthcare solutions developed in Atlantic Canada to customers across Canada and around the world.

To help reach a broader market, BIOMATCAN is enhancing its marketing and business-development activities with support from the Atlantic Canada Opportunities Agency (ACOA). The project is helping the company strengthen its market presence, reach new customers and distributors and support continued growth domestically and internationally.

Efforts to build awareness of its products, expand its international veterinary distribution network and build new relationships with healthcare professionals, distributors and industry partners are helping position BIOMATCAN for future growth while supporting the commercialization of Atlantic Canadian innovation.

"ACOA's support gives us the ability to invest in marketing activities at a scale that would be difficult for a small company to undertake on its own," says Nour Bakali, President and CEO of BIOMATCAN. "It has allowed us to improve our ability to communicate our technology, reach new audiences and develop commercial opportunities."

As Small Business Week celebrates entrepreneurship and innovation, BIOMATCAN demonstrates how Atlantic Canadian companies are transforming research into real-world solutions. The company continues to expand the adoption of its products, develop new biomaterial technologies and build a sustainable Canadian medical-device business that delivers healthcare benefits at home and around the world.